Chandra Bhagat Pharma Ltd Financials
Company Logo

Chandra Bhagat Pharma Ltd Financial Statement

Chandra Bhagat Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Chandra Bhagat Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual86.72
Operating Expenses Annual88.14
Operating Profit Annual4.06
Interest Annual1.95
Depreciation0.88
Net Profit Annual0.86
Tax Annual0.31

Chandra Bhagat Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning4.96
Cash Flow from Operations-5.58
Cash Flow from Investing-1.23
Cash Flow from Financing2.19
Cash Flow at the End0.34

Chandra Bhagat Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)4.43
PBIT Margin (%)3.33
PBT Margin (%)1.62
Net PROFIT Margin (%)0.99
Return On Networth / Equity (%)2.41
Return On Networth /Employed (%)5.98
Return On Assets (%)1.79
Total Debt / Equity (X)0.63
Asset Turnover Ratio (%)1.80

Chandra Bhagat Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual2.62
Total Current Assets Annual97.45
Non Current Assets Annual4.08
Total Shareholders Funds Annual29.97
Total Assets Annual101.53

Chandra Bhagat Pharma Ltd Earning Calls

No Data Availabe

FAQS on Chandra Bhagat Pharma Ltd Financials

As of Sep 16, 2025, Chandra Bhagat Pharma Ltd has a market capitalization of 39.48 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Chandra Bhagat Pharma Ltd is not with a debt-to-equity ratio of 0.70.

In FY 2024 , Chandra Bhagat Pharma Ltd recorded a total revenue of approximately 86.72 Cr marking a significant milestone in the company's financial performance.

Chandra Bhagat Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.3% and -0.2% annually, respectively..

Chandra Bhagat Pharma Ltd's current PE ratio is 45.91.

Chandra Bhagat Pharma Ltd's ROCE averaged 7.0% from the FY ending March 2023 to 2025, with a median of 6.9%. It peaked at 8.0% in March 2024, reflecting strong capital efficiency over the period..

Chandra Bhagat Pharma Ltd's latest EBIT is Rs. 3.12 Cr, surpassing the average EBIT of Rs. 3.37 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions